A population-based study of pain and quality of life during the year before death in men with prostate cancer

Overview of attention for article published in British Journal of Cancer, February 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

policy: 2 policy sources

Readers on

mendeley: 49 Mendeley

Summary Policy documents

So far, Altmetric has seen 4 policy documents that reference this research output.

Olaparib (Lynparza) for metastatic castration-resistant prostate cancer - Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer : Appraisal consultation committee papers 1

Cited by National Institute for Health and Care Excellence on 18 Aug 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel: Committee papers

Cited by National Institute for Health and Care Excellence on 01 Feb 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen: Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): evaluation report

Cited by National Institute for Health and Care Excellence on 18 Oct 2013

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.